A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess treatment satisfaction on Day 57 in participants with
Actinic Keratoses (AK) of the face or scalp following treatment with tirbanibulin ointment 1
percent (%) administered once daily for 5 consecutive days.